At the research center “Vector” are large-scale preclinical studies of a new vaccine. Human trials planned to start in about two weeks. According to forecasts, the drug from the coronavirus will be fully ready by mid-September. About its effectiveness in an interview Naila Asker-zade said the head of Rospotrebnadzor Anna Popova.
“In early March, whole genome sequences available to the world community, posted on certain Internet resources, was, in my opinion, 163. And today it is more than 36 thousand of the investigated viruses, coronaviruses, already a man struck. That is, each of them had its manifestation is unpleasant, clinical. Scientists say that the virus has a small number of changes, a small number of mutations, and this gives us reason to believe that the vaccine can be invented, and it can be quite effective. From what we see today, how the virus behaves today,” she said.
the full interview, which the head of Rospotrebnadzor Anna Popova gave Naila Asker-zade, will be aired on the TV channel “Russia 24” on Sunday, may 31, after 16:00 Moscow time.
